Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interaction between hypothalamic peptides in a superfused pituitary cell system.

S Vigh, A V Schally

    Peptides
    |January 1, 1984
    PubMed
    Summary

    Researchers studied hypothalamic releasing factors like corticotropin-releasing factor (CRF) and growth hormone-releasing factor (GH-RF). They found these factors influence pituitary hormone release and interact with brain peptides, indicating complex control mechanisms.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Growth inhibition of estrogen-dependent and estrogen-independent MXT mammary cancers in mice by the bombesin and gastrin-releasing peptide antagonist RC-3095.

    Journal of the National Cancer Institute·1992
    Same author

    Inhibitory effects of the new bombesin receptor antagonist RC-3095 on the luteinizing hormone release in rats.

    Neuroendocrinology·1992
    Same author

    Reduced postpartum anestrus of suckled beef cows treated with microencapsulated luteinizing hormone-releasing hormone analog.

    Journal of animal science·1992
    Same author

    Treatment of liver metastases of human colon cancers in nude mice with somatostatin analogue RC-160.

    International journal of cancer·1992
    Same author

    Inhibitory effect of somatostatin analogue RC-160 on the growth of hepatic metastases of colon cancer in rats: a study with magnetic resonance imaging.

    Cancer research·1992
    Same author

    High potency of a new bombesin antagonist (RC-3095) in inhibiting serum gastrin levels; comparison of different routes of administration.

    Regulatory peptides·1992

    Area of Science:

    • Neuroendocrinology
    • Molecular Endocrinology
    • Cellular Biology

    Background:

    • Hypothalamic releasing factors, corticotropin-releasing factor (CRF) and growth hormone-releasing factor (GH-RF), have been isolated and synthesized.
    • Previous studies assessed their biological potencies using in vivo and in vitro methods, including rat pituitary cell cultures.

    Purpose of the Study:

    • To investigate the dynamics of pituitary hormone release in response to CRF and GH-RF.
    • To examine the interactions between CRF, GH-RF, and various brain peptides within a pituitary cell-superfusion system.

    Main Methods:

    • Utilized a pituitary cell-superfusion system to study hormone release dynamics.
    • Administered synthetic CRF and GH-RF variants, as well as purified porcine GH-RF, to pituitary cells.

    Related Experiment Videos

  • Investigated interactions with brain peptides including vasopressin, SP, and PHI-27.

    • Main Results:

    • Demonstrated a dose-related release of adrenocorticotropic hormone (ACTH) upon superfusion with synthetic CRF.
    • Showcased dose-related releases of growth hormone (GH) induced by synthetic hGH-RF variants and porcine GH-RF.
    • Confirmed interactions between CRF and vasopressin/SP, and between hGH-RF and vasopressin/PHI-27.

    Conclusions:

    • Pituitary hormone secretion is regulated by a complex interplay of factors.
    • Releasing factors and brain peptides interact to modulate the control of pituitary hormone secretion.